AKCA
Akcea Therapeutics Inc
AKCA
AKCA
Delisted
AKCA was delisted on the 9th of October, 2020.
74 hedge funds and large institutions have $665M invested in Akcea Therapeutics Inc in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 34 increasing their positions, 15 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
6% less capital invested
Capital invested by funds: $704M → $665M (-$39.1M)
Holders
74
Holding in Top 10
–
Calls
$16.1M
Puts
$11.9M
Top Buyers
| 1 | +$12M | |
| 2 | +$7.14M | |
| 3 | +$2.63M | |
| 4 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
+$2.11M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.35M |
Top Sellers
| 1 | -$19.3M | |
| 2 | -$9.3M | |
| 3 | -$3.55M | |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
-$803K |
| 5 |
AGA
Altrinsic Global Advisors
Stamford,
Connecticut
|
-$708K |